Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Magnetic Resonance Imaging × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Neoplasms 1 Hodgkin Disease 1 Glioma 1 Disease 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 12 Specimen Handling 9 Temozolomide 8 Radiotherapy 6 Biopsy 6 trametinib 5 X-Rays 5 Radiation 5 erdafitinib 4 dabrafenib 4 Phantoms, Imaging 4 Nuclear Medicine Department, Hospital 4 Bevacizumab 4 ulixertinib 3 palbociclib 3 abemaciclib 3 tazemetostat 2 olaparib 2 lutetium Lu 177 dotatate 2 larotrectinib 2 ivosidenib 2 entrectinib 2 ensartinib 2 contrast agent BR1 2 binimetinib 2 Standard of Care 2 Spinal Puncture 2 Practice Guidelines as Topic 2 Nivolumab 2 LY3023414 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07488780 2026-03-23

Language Network Prehab Via fMRI Neurofeedback

Yale University

Phase NA Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡